Effects of post COVID-19 on lungs in tertiary care hospital, Peshawar

Saadia Anwar; Iqra Heer Bhatti; Amna Mughal; Samia Shoukat Abbasi; Nadia Shabnam; Muhammad Sheraz Qureshi; Ariba Ariba; Farhaz R Malik

doi:10.53730/ijhs.v6nS8.13898

Authors

Saadia Anwar Senior Lecturer, Department of Physiology, Jinnah Medical College, Peshawar, Pakistan
Iqra Heer Bhatti Dr Ziauddin Hospital, Kemari Campus Karachi, General Surgery Department
Amna Mughal Anatomy Department, Jinnah Sindh Medical University Karachi
Samia Shoukat Abbasi Department of Bioscience, COMSATS University Islamabad
Nadia Shabnam Assistant professor, Department of Health Profession Education, National University of Medical Sciences, Islamabad
Muhammad Sheraz Qureshi Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University Multan
Ariba Department of Life Sciences, School of Science, University of Management and Technology, Lahore, Pakistan
Farhaz R Malik
drfarhatmalik@gmail.com
Professor, Community Health Sciences Department, Peshawar Medical College. Warsak road. Peshawar. Riphah International University. Islamabad. Pakistan

Keywords:

post COVID-19, decortications, pulmonary, surgical treatments

Abstract

Background: A severe acute respiratory virus that started lethal lung infections in Wuhan, China in Dec 2019 swiftly evolved into an epidemic in March 2020. Millions of fatalities have been attributed to COVID-19 globally, and people who survived the acute type often experience major mortality. Objective: The purpose of this research was to describe a number of patients who had experienced pulmonary problems following COVID-19. Methods: From December 2021 to June 2022, a retrospective research was done in Hayatabad Medical Complex, Peshawar. Patients with a record of a COVID-19 diagnosis verified by nasopharyngeal RT-PCR and who had been hospitalized to or visited an outpatient department were included. Results: This research included a total of 50 COVID-19 infected individuals. patients most frequently reported shortness of breath (n=29; 58%), fever (n=7; 14%), cough (n=5; 10%), and hemoptysis (n=9; 18%). Major surgical treatments were carried out on them, including bullectomies, lobectomies, and decortications and the most successful treatment for empyema is open decortication. Thirteen patients (26%) were admitted to the ICU after operations, nine cases (18%) acquired mucormycosis, and two deaths were reported.

Downloads

Download data is not yet available.

References

A. Nalbandian, K. Sehgal, A. Gupta, M.V. Madhavan, C. McGroder, J.S. Stevens, et al., Post-acute COVID-19 syndrome, Nat. Med. 27 (4) (2021) 601–615.

A.K. Boutou, A. Asimakos, E. Kortianou, I. Vogiatzis, A. Tzouvelekis, Long COVID19 pulmonary sequelae and management considerations, J. Personalized Med. 11 (9) (2021) 838

A.M. Hamad, A.F. Elmahrouk, O.A. Abdulatty, Alveolar air leakage in COVID-19 patients: pneumomediastinum and/or pneumopericardium, Heart Lung 49 (6) (2020) 881–882.

Ahmed, O. F., Amin, B. J. H., Abdullah, B. A., Hassan, M. N., Salih, R. Q., Mohammed, S. H., ... & Salih, A. M. (2021). Post COVID-19 pulmonary complications; a single center experience. Annals of Medicine and Surgery, 72, 103052.

Buja, L. M., Wolf, D. A., Zhao, B., Akkanti, B., McDonald, M., Lelenwa, L., ... & Kar, B. (2020). The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovascular Pathology, 48, 107233.

Burke, R. M., Killerby, M. E., Newton, S., Ashworth, C. E., Berns, A. L., Brennan, S., ... & Case Investigation Form Working Group. (2020). Symptom profiles of a convenience sample of patients with COVID-19—United States, January–April 2020. Morbidity and Mortality Weekly Report, 69(28), 904.

Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. (2020) 20:1135–40. doi: 10.1101/2020.04.19.2005 4262

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020) 395:507–13. doi: 10.1016/S0140-6736(20)30211-7

Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a Nationwide Analysis. Eur Respir J. (2020) 55:2000547. doi: 10.1183/13993003.01227- 2020

H. Shi, X. Han, N. Jiang, Y. Cao, O. Alwalid, J. Gu, et al., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect. Dis. 20 (4) (2020) 425–434.

J.J. Solomon, B. Heyman, J.P. Ko, R. Condos, D.A. Lynch, CT of postacute lung complications of COVID-19, Radiology 1 (1) (2021) 1–13.

Kassam, N., Aghan, E., Aziz, O., Mbithe, H., Hameed, K., Shah, R., ... & Somji, S. (2021). Factors associated with mortality among hospitalized adults with COVID-19 pneumonia at a Private Tertiary Hospital in Tanzania: A retrospective cohort study. International journal of general medicine, 14, 5431.

Liu D, Zhang W, Pan F, Li L, Yang L, Zheng D, et al. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res. (2020) 21:1–7. doi: 10.1186/s12931-020-01 385-1

Liu K, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. (2020) 133:1025– 31. doi: 10.1097/CM9.0000000000000744.

Pakistan Government. COVID-19 Health advisory platform by Ministry of National Health Services Regulations & Coordination 2021. Available from: https://covid.gov.pk/stats/pakistan.

Udwadia, Z. F., Tripathi, A. R., Nanda, V. J., & Joshi, S. R. (2020). Prognostic factors for adverse outcomes in COVID-19 infection. J Assoc Physicians India, 68(7), 56-60.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061–9. doi: 10.1001/jama.2020.1585

World Health Organization. (2020). Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020 (No. WHO/COVID-19/laboratory/2020.4). World Health Organization.

Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., ... & Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934-943.

Zhang, C., Yang, L., Liu, S., Ma, S., Wang, Y., Cai, Z., ... & Zhang, B. (2020). Survey of insomnia and related social psychological factors among medical staff involved in the 2019 novel coronavirus disease outbreak. Frontiers in psychiatry, 11, 306.